期刊文献+

反相高效液相色谱法测定盐酸哌罗匹隆原料药含量

Determination of the concentration of perospirone hydrochloride by RP-HPLC
原文传递
导出
摘要 目的:建立了反相高效液相色谱法测定盐酸哌罗匹隆原料药含量及有关物质,为哌罗匹隆原料药的含量和有关物质测定提供检测方法,制定质控标准。方法:色谱柱为依利特Hypersil ODS C18柱(250mm×4.6 mm,5μm),流动相为磷酸盐缓冲液(含1.02%磷酸二氢钾和0.4%庚烷磺酸钠,用磷酸调pH3.0)-乙腈(60∶40),流速为1.0 mL.min-1;检测波长为230 nm;柱温为30℃。结果:主峰能与相邻杂质峰较好分离,哌罗匹隆的浓度在37.1~111.4μg.mL-1范围内线形关系良好,相关系数为0.999 9。结论:该法简便、准确、专属性好,可以用于盐酸哌罗匹隆原料药的含量测定。 Objective: To establish a RP-HPLC method for the determination of concentration of perospitone hydrochloride and its related substances. Methods: The HPLC condition was as follows: a C18 column (250 mm×4.6 mm,5μm) with a column temperature at 30 ℃ , an eluate of 1.02% potassium dihydrogen phosphate and 0.4% 1-Heptanesulfonic acid, pH = 3.0 [ adjusted with phosphoric acid-acetonitrile (60: 40) ], a flow rate of 1.0 mL·min^-1 and detection at 230nm. Results: Perospirone hydrochloride was compeletely separated from impurities. The calibrated linear curve of perospirone was within 37.1 - 111.4 μg·mL^-1 with the correlation coefficient of 0. 999 9. The average recovery was 100.9% (RSD = 1.3% ). Conclusion: This RP-HPLC method is accurate, reliable, and applicable for the quality control of perospirone hydrochloride and its related substances.
出处 《中国新药杂志》 CAS CSCD 北大核心 2009年第21期2089-2092,共4页 Chinese Journal of New Drugs
关键词 高效液相色谱法 盐酸哌罗匹隆 含量测定 HPLC perospirone hydrochloride assay
  • 相关文献

参考文献4

  • 1YOSHINO T, NISIJIMA K, SHIODA K,et al. Perospirone, a novel atypical antlpsychotic drug,potentlates fluoxetinelnduced increases in dopamine levels via multireceptor actions in the rat medial prefrontal cortex [ J]. Neurosci Lett ,2004,364( 1 ) : 16 - 21.
  • 2涂继莹,左笑丛,李焕德.非典型抗精神病药——哌罗匹隆[J].中国临床药理学杂志,2007,23(2):157-160. 被引量:25
  • 3YASUI-FURUKORI N, INOUE Y ,TATEISHI T. Determination of a new atypical antipsychotic agent perospirone and its metabolite in human plasma by automated column-switching high-performance liquid chromatography [ J ] . J Chromatogr B, 2003, 789 (2) :239 - 245.
  • 4LI KY,ZHOU YG,REN HY,et al. Ultra-performance liquid chromatography-tandem mass spectrometry for the determination of atypical antipsychotics and some metabolites in in vitro samples [ J ]. J Chromatogr B ,2007,850 ( 1-2 ) :581 - 585.

二级参考文献20

  • 1Yoshino T, Nisijima K, Shioda K, et al. Perospirone, a novel atypical antipsychotic drug, potentiates fluoxetine - induced increases in dopamine levels via multireceptor actions in the rat medial prefrontal cortex [J]. Neurosci Lett, 2004; 1:16 -21.
  • 2Mizuno Y, Komuro S, Kanamaru H. Distribution of perospirone to me -lanin in pigmented rats [ J ]. Eur J Drug Metabol Pharmacokinet ,2003;28:73 - 79.
  • 3Shimakura J, Tani N, Mizuno Y,et al. In vitro drug -drug interactions with perospirone and concomitantly administered drugs in human liver microsomes [J].Eur J Drug Metabolism Pharmacokinet, 2003 ; 28 : 67-72.
  • 4Takahashi Y, Kusumi I, Ishikane T,et al. In vivo occupation of dopamine D2,Dl and serotonin 2A receptors by novel antinpsychotic drug,SM-9018 and its metabolite, in rat brain [J]. J Neural Transm,1998;105:181 -191.
  • 5Iwakawa M, Terao T, Soya A,et al. A novel antipsychotic, perospirone has antiserotonergic and antidopaminergic effects in human brain:findings from merroendocrine challenge tests [ J ]. Psychophamacology,2004; 176:407-411.
  • 6Terumasa O, Chihiro I, Eiko S,et al. Effects of serotonin - dopamine antagonists on prepulse inhibition and neurotransmitter contents in the rat cortex [ J ]. Neurosci Lett,2004 ; 366 : 130 - 134.
  • 7Tadashi I, Yukihiro O. Perospirone hydrochloride: the novel atypical antipsychotic agent with high affinities for 5 - HT2, D2 and 5 - HT1A receptors [ J ]. Biogenic Amines, 2004 ; 18 : 307 - 317.
  • 8Masui T, Honma H, Kondo C ,et al. Perospirone therapy in elderly patients with schizophrenia Seishin Shinkeigaku Zasshi - Psychiatria[J]. Neurol Jpn, 2003 ;105:1247 - 1253.
  • 9Takuya M, Iciro K, Yoshito T,et al. Efficacy of carbamazepine against neuroleptic -induced akathisia in treatment with perospirone: case series[ J ]. Neuro - Psychopharmacol Biol Psychiatr, 2005 ; 29 : 343 -346.
  • 10Tsuyoshi A, Hidenori Y, Tomiki S. Perospirone in the treatment of schizophrenia:Effect on verbal memory organization [ J ]. Neuro -Psychopharmacol Biol Psychiatr ,2006 ;30:204 - 208.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部